Alexander Schmitz
Partner
Alexander joined Endeavour in 2015 to lead investments in medical technology across therapeutic areas and became a Partner in 2018. He has led or co-led the firm’s investments in Kestra Medical Technologies (NASDAQ: KMTS), Gynesonics (acquired by Hologic), Nalu Medical (acquired by Boston Scientific), Nuvaira, Relievant Medsystems (acquired by Boston Scientific), FLEX Vascular, Vertiflex (acquired by Boston Scientific), and V-Wave (acquired by J&J MedTech), among others, and has served on the boards of most of them.
Before Endeavour, Alexander spent 10 years with Biosensors International Group, an interventional cardiology company, latterly as Vice President of Business Development reporting to the CEO; he was part of the core team that established the group’s European commercial operations and helped scale the business to over USD 300m in revenue. Earlier he worked at LogiSpring Ventures, MicroStrategy and McKinsey & Company. Alexander holds an MBA from INSEAD and a BSFS magna cum laude from Georgetown University’s School of Foreign Service, where he was a Krogh Scholar.